A thorough understanding of the broad spectrum of clinical manifestations of PD is essential to the proper diagnosis of the disease. Genetic mutations or variants, neuroimaging abnormalities and other tests are potential biomarkers that may improve diagnosis and allow the identification of persons at risk.
No takes yet. Share an insight, caveat, or question.
Joseph Jankovic (2008) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: